Bioelectronics Corporation (BIEL)
Bioelectronics Corporation operates in the Medical - Specialties industry of the Healthcare sector, headquartered in Frederick, MD, US. The stock last traded at $0.00, down 10.45% on the session, giving a market capitalisation of $7.4M. On trailing twelve-month figures it carries a trailing P/E of -13.92, a net margin of -104.3%. Its beta of 2.00 implies it has historically moved more than the broad market.
BioElectronics Corporation, an electroceutical company, engages in the development and sale of wearable, neuromodulation devices to mitigate neurological diseases and enhance quality of life worldwide. Its products include ActiPatch, a musculoskeletal pain therapy; Allay, a menstrual pain therapy; and Smart Insole, a heel pain therapy. The company also offers RecoveryRx, a medical device that provides pain management therapy for medical professionals; and HealFast, a drug-free therapy for horses, cats, and dogs that reduces swelling and pain, as well as heals muscle and tendon injuries, sores, and incisions. It sells its products to wholesale distributors, hospitals and clinics, and consumers. The company was incorporated in 2000 and is headquartered in Frederick, Maryland.
Bioelectronics Corporation is most often compared with the following Healthcare names: